Canopy Growth Corp (CGC) Scorecard
- 2026-Q2: Total return Lose; Revenue growth No data; EPS growth No data.
- 2026-Q1: Total return Lose; Revenue growth No data; EPS growth No data.
- 2025-Q4: Total return Lose; Revenue growth No data; EPS growth No data.
- 2025-Q3: Total return Win; Revenue growth No data; EPS growth No data.
16/40
2.0 / 5 stars
All 40 Win/Lose results and 80 gray no-data contests shown below
Every strict quarterly win earns 1 point. A loss or tie earns 0. A contest with no data is a gray cell, neither a win nor a loss, and leaves the total: stars are 5 × points won ÷ contests with data.
Trailing 1 year (4 quarters): 1 wins, 3 losses, 8 no dataLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/1 |
LoseCGC / S&P 0.11% / 15.20% |
No dataCGC / S&P / 15.00% |
No dataCGC / S&P / 50.40% |
| 2026-Q10/1 |
LoseCGC / S&P -16.75% / -4.33% |
No dataCGC / S&P / 11.30% |
No dataCGC / S&P / 27.70% |
| 2025-Q40/1 |
LoseCGC / S&P -21.92% / 2.65% |
No dataCGC / S&P / 9.00% |
No dataCGC / S&P / 13.40% |
| 2025-Q31/1 |
WinCGC / S&P 19.67% / 8.12% |
No dataCGC / S&P / 4.61% |
No dataCGC / S&P / 13.45% |
| 2025-Q21/1 |
WinCGC / S&P 34.07% / 10.94% |
No dataCGC / S&P / 4.83% |
No dataCGC / S&P / 10.63% |
| 2025-Q10/1 |
LoseCGC / S&P -66.79% / -4.27% |
No dataCGC / S&P / 4.98% |
No dataCGC / S&P / 10.57% |
| 2024-Q40/1 |
LoseCGC / S&P -43.15% / 2.41% |
No dataCGC / S&P / 5.25% |
No dataCGC / S&P / 6.15% |
| 2024-Q30/1 |
LoseCGC / S&P -25.27% / 5.89% |
No dataCGC / S&P / 5.89% |
No dataCGC / S&P / 6.11% |
| 2024-Q20/1 |
LoseCGC / S&P -25.26% / 4.28% |
No dataCGC / S&P / 5.38% |
No dataCGC / S&P / 5.12% |
| 2024-Q11/1 |
WinCGC / S&P 68.88% / 10.56% |
No dataCGC / S&P / 5.71% |
No dataCGC / S&P / 5.59% |
| 2023-Q40/1 |
LoseCGC / S&P -34.74% / 11.69% |
No dataCGC / S&P / 6.81% |
No dataCGC / S&P / 7.78% |
| 2023-Q31/1 |
WinCGC / S&P 101.80% / -3.27% |
No dataCGC / S&P / 7.52% |
No dataCGC / S&P / -5.03% |
| 2023-Q20/1 |
LoseCGC / S&P -77.83% / 8.74% |
No dataCGC / S&P / 9.50% |
No dataCGC / S&P / -8.57% |
| 2023-Q10/1 |
LoseCGC / S&P -24.24% / 7.50% |
No dataCGC / S&P / 10.77% |
No dataCGC / S&P / -15.69% |
| 2022-Q40/1 |
LoseCGC / S&P -15.38% / 7.56% |
No dataCGC / S&P / 11.88% |
No dataCGC / S&P / -17.99% |
| 2022-Q31/1 |
WinCGC / S&P -4.21% / -4.88% |
No dataCGC / S&P / 13.47% |
No dataCGC / S&P / -1.41% |
| 2022-Q20/1 |
LoseCGC / S&P -62.40% / -16.10% |
No dataCGC / S&P / 13.71% |
No dataCGC / S&P / 11.04% |
| 2022-Q10/1 |
LoseCGC / S&P -13.17% / -4.60% |
No dataCGC / S&P / 15.97% |
No dataCGC / S&P / 42.23% |
| 2021-Q40/1 |
LoseCGC / S&P -37.01% / 11.03% |
No dataCGC / S&P / 15.00% |
No dataCGC / S&P / 96.40% |
| 2021-Q30/1 |
LoseCGC / S&P -42.68% / 0.58% |
No dataCGC / S&P / 10.77% |
No dataCGC / S&P / 69.42% |
| 2021-Q20/1 |
LoseCGC / S&P -24.51% / 8.55% |
No dataCGC / S&P / 6.58% |
No dataCGC / S&P / 51.81% |
| 2021-Q11/1 |
WinCGC / S&P 29.99% / 6.17% |
No dataCGC / S&P / -1.06% |
No dataCGC / S&P / 7.39% |
| 2020-Q41/1 |
WinCGC / S&P 72.07% / 12.15% |
No dataCGC / S&P / -3.72% |
No dataCGC / S&P / -33.42% |
| 2020-Q30/1 |
LoseCGC / S&P -11.39% / 8.93% |
No dataCGC / S&P / -2.04% |
No dataCGC / S&P / -27.10% |
| 2020-Q20/1 |
LoseCGC / S&P 12.07% / 20.54% |
No dataCGC / S&P / -0.46% |
No dataCGC / S&P / -27.11% |
| 2020-Q10/1 |
LoseCGC / S&P -31.63% / -19.60% |
No dataCGC / S&P / 3.47% |
No dataCGC / S&P / -14.75% |
| 2019-Q40/1 |
LoseCGC / S&P -8.02% / 9.07% |
No dataCGC / S&P / 5.36% |
No dataCGC / S&P / 2.99% |
| 2019-Q30/1 |
LoseCGC / S&P -43.12% / 1.70% |
No dataCGC / S&P / 5.02% |
No dataCGC / S&P / 0.21% |
| 2019-Q20/1 |
LoseCGC / S&P -7.06% / 4.30% |
No dataCGC / S&P / 6.64% |
No dataCGC / S&P / 8.65% |
| 2019-Q11/1 |
WinCGC / S&P 61.41% / 13.65% |
No dataCGC / S&P / 8.12% |
No dataCGC / S&P / 14.29% |
| 2018-Q40/1 |
LoseCGC / S&P -44.76% / -13.52% |
No dataCGC / S&P / 9.05% |
No dataCGC / S&P / 18.23% |
| 2018-Q31/1 |
WinCGC / S&P 66.06% / 7.71% |
No dataCGC / S&P / 10.21% |
No dataCGC / S&P / 19.06% |
| 2018-Q21/1 |
WinCGC / S&P 12.12% / 3.43% |
No dataCGC / S&P / 9.03% |
No dataCGC / S&P / 14.46% |
| 2018-Q11/1 |
WinCGC / S&P 10.43% / -0.76% |
No dataCGC / S&P / 7.68% |
No dataCGC / S&P / 12.46% |
| 2017-Q41/1 |
WinCGC / S&P 175.07% / 6.64% |
No dataCGC / S&P / 7.03% |
No dataCGC / S&P / 13.82% |
| 2017-Q31/1 |
WinCGC / S&P 40.34% / 4.48% |
No dataCGC / S&P / 5.68% |
No dataCGC / S&P / 17.57% |
| 2017-Q20/1 |
LoseCGC / S&P -23.40% / 3.09% |
No dataCGC / S&P / 4.83% |
No dataCGC / S&P / 17.74% |
| 2017-Q11/1 |
WinCGC / S&P 17.30% / 6.07% |
No dataCGC / S&P / 3.67% |
No dataCGC / S&P / 13.32% |
| 2016-Q41/1 |
WinCGC / S&P 122.29% / 3.82% |
No dataCGC / S&P / 2.09% |
No dataCGC / S&P / 7.05% |
| 2016-Q31/1 |
WinCGC / S&P 45.54% / 3.85% |
No dataCGC / S&P / 0.20% |
No dataCGC / S&P / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | CGC total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -43.89% | 20.78% |
| Annualized return | -43.89% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | CGC total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -99.40% | 83.14% |
| Annualized return | -64.06% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | CGC total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -96.52% | 319.30% |
| Annualized return | -28.52% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |